Association of human cytomegalovirus DNAaemia and specific granzyme B responses in lung transplant recipients

Clinical and Experimental Immunology

Volumn 173, Issue 3, 2013, Pages 438-443

  Weseslindtner, L ^a   Kerschner, H ^a   Steinacher, D ^a   Kundi, M ^a   Jaksch, P ^a   Simon, B ^a   Hatos Agyi, L ^a   Scheed, A ^a   Klepetko, W ^a   Puchhammer Stockl E ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytomegalovirus; DNAaemia; Granzyme B; HCMV; Lung transplant recipients

Indexed keywords

GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN; VALGANCICLOVIR; VIRUS DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS DETECTION; VIRUS LOAD;

CYTOMEGALOVIRUS; DNAAEMIA; GRANZYME B; HCMV; LUNG TRANSPLANT RECIPIENTS;

ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GRANZYMES; HUMANS; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; VIRAL LOAD;

EID: 84881532098     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12123     Document Type: Article

References (22)

1. Humar A, Snydman D. Cytomegalovirus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 4):S78-86.
2. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 2003; 75:2064-2068.
3. Emery VC, Sabin CA, Cope AV, Gor D, Hassan-Walker AF, Griffiths PD. Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 2000; 355:2032-2036.
4. Harari A, Enders FB, Cellerai C, Bart PA, Pantaleo G. Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J Virol 2009; 83:2862-2871.
5. Bannard O, Kraman M, Fearon D. Pathways of memory CD8+ T-cell development. Eur J Immunol 2009; 39:2083-2087.
6. Giulieri S, Manuel O. QuantiFERON(R)-CMV assay for the assessment of cytomegalovirus cell-mediated immunity. Exp Rev Mol Diagn 2011; 11:17-25.
7. Kumar D, Chernenko S, Moussa G etal. Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients. Am J Transplant 2009; 9:1214-1222.
8. Lisboa LF, Kumar D, Wilson LE, Humar A. Clinical utility of cytomegalovirus cell-mediated immunity in transplant recipients with cytomegalovirus viremia. Transplantation 2012; 93:195-200.
9. Manuel O, Husain S, Kumar D etal. Assessment of cytomegalovirus specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clin Infect Dis 2013; 56:817-824.
10. Weseslindtner L, Kerschner H, Steinacher D etal. Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T-cell responses in lung transplant recipients. Am J Transplant 2012; 12:2172-2180.
11. Chattopadhyay PK, Betts MR, Price DA etal. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 2009; 85:88-97.
12. Wever PC, Spaeny LH, van der Vliet HJ etal. Expression of granzyme B during primary cytomegalovirus infection after renal transplantation. J Infect Dis 1999; 179:693-696.
13. Gamadia LE, Rentenaar RJ, Baars PA etal. Differentiation of cytomegalovirus-specific CD8(+) T cells in healthy and immunosuppressed virus carriers. Blood 2001; 98:754-761.
14. Hertoghs KM, Moerland PD, van Stijn A etal. Molecular profiling of cytomegalovirus-induced human CD8+ T cell differentiation. J Clin Invest 2010; 120:4077-4090.
15. Jukes JP, Wood KJ, Jones ND. Bystander activation of iNKT cells occurs during conventional T-cell alloresponses. Am J Transplant 2012; 12:590-599.
16. Remmerswaal EB, Havenith SH, Idu MM etal. Human virus-specific effector-type T cells accumulate in blood but not in lymph nodes. Blood 2012; 119:1702-1712.
17. Northfield JW, Kasprowicz V, Lucas M etal. CD161 expression on hepatitis C virus-specific CD8+ T cells suggests a distinct pathway of T cell differentiation. Hepatology 2008; 47:396-406.
18. Hersperger AR, Martin JN, Shin LY etal. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood 2011; 117:3799-3808.
19. Ribeiro-Dos-Santos P, Turnbull EL, Monteiro M etal. Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors. Blood 2012; 119:4928-4938.
20. Clari MA, Munoz-Cobo B, Solano C etal. Performance of the QuantiFERON-cytomegalovirus (CMV) assay for detection and estimation of the magnitude and functionality of the CMV-specific gamma interferon-producing CD8(+) T-cell response in allogeneic stem cell transplant recipients. Clin Vaccine Immunol 2012; 19:791-796.
21. Betts MR, Nason MC, West SM etal. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006; 107:4781-4789.
22. Gerna G, Lilleri D, Chiesa A etal. Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation. Am J Transplant 2011; 11:2463-2471.